CHEBI:15765Papers
Indexed under CHEBI:15765 in PubMed's chemical list
- papers
- 62
Newest first
1 to 50 of 62Association of serum homocysteine, folate, and vitamin B₁₂ levels with cognitive function in levodopa-naïve patients with Parkinson's disease and mild cognitive impairment.
Neurologia i neurochirurgia polska2026PMID 42411114
Randomized, placebo-controlled trial of N-acetylcysteine in Parkinson's disease patients: a pilot study.
Metabolic brain disease2026PMID 42776345
Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Journal of inherited metabolic disease2025PMID 41215497
Can we add whey protein supplementation in patients with Parkinson's disease without interfering with levodopa response?
The International journal of neuroscience2024PMID 36786430Also indexed under CHEBI:15765 as a PubMed major topic
Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.
Movement disorders2024PMID 38850081Also indexed under CHEBI:15765 as a PubMed major topic
A systematic review of the potential consequences of abnormal serum levels of vitamin B6 in people living with Parkinson's disease.
Journal of the neurological sciences2023PMID 37210937
Fucoxanthin Prevents Long-Term Administration l-DOPA-Induced Neurotoxicity through the ERK/JNK-c-Jun System in 6-OHDA-Lesioned Mice and PC12 Cells.
Marine drugs2022PMID 35447917
Trial of Deferiprone in Parkinson's Disease.
The New England journal of medicine2022PMID 36449420
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Signal transduction and targeted therapy2021PMID 33623004
Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study.
Journal of clinical neuroscience2021PMID 33992189
Parkinson's disease: Research puts spotlight on thiamine deficiency and cardiovascular health.
Journal of clinical neuroscience2021PMID 34167881
The Effect of Caffeine on the Risk and Progression of Parkinson's Disease: A Meta-Analysis.
Nutrients2020PMID 32580456
Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson's disease in experimental animals.
Behavioural pharmacology2018PMID 28902670
Hair in Parkinson's disease patients exhibits differences in Calcium, Iron and Zinc concentrations measured by flame atomic absorption spectrometry - FAAS.
Journal of trace elements in medicine and biology2018PMID 29544800
Proposition of zinc supplementation during levodopa-carbidopa intestinal gel treatment.
Brain and behavior2018PMID 30358126
Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson's disease: A meta-analysis.
Neuroscience letters2017PMID 27840145
Caffeine consumption and the 4-year progression of de novo Parkinson's disease.
Parkinsonism & related disorders2016PMID 27622969
Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
Saudi journal of kidney diseases and transplantation2015PMID 25758874
Neuroprotective potential of Beta vulgaris L. in Parkinson's disease.
Indian journal of pharmacology2015PMID 26288473
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.
Sleep medicine2014PMID 24529544
Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.
Parkinsonism & related disorders2013PMID 23283428
Caffeine consumption and risk of dyskinesia in CALM-PD.
Movement disorders2013PMID 23339054
Effect of nicotine on the pharmacokinetics of levodopa.
Clinical neuropharmacology2013PMID 23503546
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
Neurotoxicity research2012PMID 21830163
The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
Neurotoxicity research2012PMID 22407500
Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.
Acta neurologica Scandinavica2011PMID 20569228
Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.
The American journal of geriatric pharmacotherapy2011PMID 21507731
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
European neurology2011PMID 21701174
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
Annals of the New York Academy of Sciences2010PMID 20201847
Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.
PloS one2010PMID 20700524
The effects of systemic, intrastriatal, and intrapallidal injections of caffeine and systemic injections of A2A and A1 antagonists on forepaw stepping in the unilateral 6-OHDA-lesioned rat.
Psychopharmacology2009PMID 18791705
Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry2009PMID 18977820
Cysteine elevation in levodopa-treated patients with Parkinson's disease.
Movement disorders2009PMID 19243072
Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency.
Archives of neurology2008PMID 18332253
Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
Pharmacological reports2008PMID 18622056
Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
European journal of neurology2008PMID 18637826
Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study.
Acta neurologica Scandinavica2007PMID 17156266
Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Archives of neurology2007PMID 17353373
Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.
Journal of psychiatry & neuroscience2007PMID 17353942
A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities.
Environmental research2007PMID 17445792
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Archives of neurology2007PMID 17502459
Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia.
Neurology2006PMID 17190955
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression.
Movement disorders2005PMID 15895421
Short-term paroxetine treatment does not alter the motor response to levodopa in PD.
Neurology2005PMID 15911816
Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.
Journal of neurology, neurosurgery, and psychiatry2004PMID 14742609
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
Movement disorders2004PMID 14743357
Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease.
Clinical neuropharmacology2004PMID 15190235
Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.
Renal failure2004PMID 15462107
Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
Movement disorders2003PMID 12722164
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.
The Journal of clinical psychiatry2002PMID 12088163